MGNX
MGNX
NASDAQ · Biotechnology

Macrogenics Inc

$1.81
+0.11 (+6.47%)
As of Feb 8, 2:10 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 20.64M 19.43M 16.17M
Net Income 4.40M 4.04M 2.70M
EPS
Profit Margin 21.3% 20.8% 16.7%
Rev Growth +16.0% +14.5% +17.0%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 7.36M 6.65M 6.76M
Total Equity 36.38M 36.37M 40.78M
D/E Ratio 0.20 0.18 0.17
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 5.96M 6.14M 4.71M
Free Cash Flow 3.87M 2.37M 2.40M